A Medical Device Daily
Spectranetics (Colorado Springs, Colorado) said that its board has named Emile Geisenheimer, the company's chairman, to the additional roles of president/CEO following the resignation of John Schulte as president/CEO and as a director of the company.
Geisenheimer has served as a director of Spectranetics since April 1990 and was appointed chairman in June 1996. He also served as acting president and CEO from May 2002 through January 2003.
Spectranetics makes an excimer laser for use in minimally invasive cardiovascular procedures. This technology treats cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream.
The Colorado Springs Police Department and Immigration and Customs Enforcement agents raided Spectranetics in early September requesting information and correspondence relating to products used in the treatment of in-stent restenosis, such as catheter guidewires and balloon catheters made by certain third parties outside the U.S. The company said that federal authorities are also seeking information on two post-market studies completed during the period from 2002 to 2005 and payments made to personnel in connection with those studies, as well as on compensation packages for certain company employees (Medical Device Daily, Sept. 8, 2008).